GZMK antibody (AA 51-250)
Quick Overview for GZMK antibody (AA 51-250) (ABIN872626)
Target
See all GZMK AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- AA 51-250
-
Cross-Reactivity
- Mouse
-
Predicted Reactivity
- Human,Rat,Horse
-
Purification
- Purified by Protein A.
-
Immunogen
- KLH conjugated synthetic peptide derived from human Granzyme K
-
Isotype
- IgG
-
-
-
-
Application Notes
-
WB 1:300-5000
ELISA 1:500-1000 -
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1 μg/μL
-
Buffer
- 0.01M TBS( pH 7.4) with 1 % BSA, 0.02 % Proclin300 and 50 % Glycerol.
-
Preservative
- ProClin
-
Precaution of Use
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
-
Storage
- 4 °C,-20 °C
-
Storage Comment
- Shipped at 4°C. Store at -20°C for one year. Avoid repeated freeze/thaw cycles.
-
Expiry Date
- 12 months
-
-
- GZMK (Granzyme K (Granzyme 3, Tryptase II) (GZMK))
-
Alternative Name
- Granzyme K
-
Background
-
Synonyms: Fragmentin 3, Fragmentin-3, Fragmentin3, GRAK_HUMAN, Granzyme 3, Granzyme K, Granzyme K precursor, Granzyme-3, Granzyme3, GranzymeK, GZMK, NK TRYP 2, NK TRYP2, NK tryptase 2, NK-TRYP-2, NK-tryptase-2, NKTRYP2, Serine protease granzyme 3, TRYP 2, TRYP2, Tryptase II, TryptaseII.
Background: This gene product is a member of a group of related serine proteases from the cytoplasmic granules of cytotoxic lymphocytes. Cytolytic T lymphocytes (CTL) and natural killer (NK) cells share the remarkable ability to recognize, bind, and lyse specific target cells. They are thought to protect their host by lysing cells bearing on their surface 'nonself' antigens, usually peptides or proteins resulting from infection by intracellular pathogens. The protein described here lacks consensus sequences for N-glycosylation present in other granzymes. [provided by RefSeq, Jul 2008].
-
Gene ID
- 3003
Target
-